non-steroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD) research hub

Long-term effect of Dupilumab on acetylsalicylic acid (ASA) intolerance and its mechanisms in patients with non-steroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD)

This study looks at how a medicine called Dupixent (Dupilumab) might help people with a condition called N-ERD to tolerate aspirin better. Researchers will compare how much aspirin people can take before and after 6 months of Dupixent treatment.